2017 Connecticut Cancer Partnership Annual Meeting Presenters & Presentation Slides

  Event Held on Tuesday, Dec. 5, 2017 Screening Guidelines and Shared Decision-Making Challenges, Controversy, Disparities Event Agenda and Acknowledgements Our speakers included: Beth Jones, PhD, MPH, Director, Smilow Screening & Prevention Program, Assistant Director for Diversity and Health Equity, Yale Cancer Center, Research Scientist and Lecturer, Yale School of Public Health .  Dr. Jones is a cancer epidemiologist whose work and teaching focus is on health disparities. Her current research is focused on racial/ethnic differences in cancer screening and cancer outcomes. Cancer Screening: Setting the Stage – Challenges, Controversy and Health Disparities Polly Sather, MSN, APRN, Advanced Practice Registered Nurse (APRN)…

Adopting Survivorship Care Plans and the Commission on Cancer’s Implementation Standard

By the Connecticut Cancer Partnership Survivorship Committee with
Marion Morra and Lucinda Hogarty

Adoption of survivorship care plans (SCP) is a key objective of The Connecticut Cancer Partnership’s 2014-2017 Connecticut Comprehensive Cancer Plans. (1) The Partnership’s Survivorship Committee is responsible for devising implementing strategies addressing this objective.



1.     Lifetime risk of developing or dying from cancer. American Cancer Society Web site.http://www.cancer.org/cancer/cancerbasics/lifetime-probability-of-developing-or-dying-from-cancer. Updated September 5, 2013. Accessed November 4, 2013. 2.     Statewide projection data. Connecticut State Data Center. Statewide Projection Data: Statewide Projections. Storrs, CT: Connecticut State Data Center. Web site.http://ctsdc.uconn.edu/projections/state_wide.html.  Accessed February 23, 2012. 3.     Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011; 103(2): 117-28. 4.     Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62: 10-29. 5.     Jemal A, Simard EP, Dorell…